Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
Apply
Recombinant Varicella Zoster Virus Vaccine
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step